1.Kidney Health Plan 2033 in Korea: bridging the gap between the present and the future
Do Hyoung KIM ; Young Youl HYUN ; Jin Joo CHA ; Sua LEE ; Hyun Kyung LEE ; Jong Wook CHOI ; Su-Hyun KIM ; Sang Youb HAN ; Cheol Whee PARK ; Eun Young LEE ; Dae Ryong CHA ; Sung Gyun KIM ; Chun Soo LIM ; Sun-Hee PARK
Kidney Research and Clinical Practice 2024;43(1):8-19
		                        		
		                        			
		                        			 In response to the increase in the prevalence of chronic kidney disease (CKD) in Korea, the growth of patients requiring renal replacement therapy and the subsequent increase in medical costs, the rapid expansion of patients with end-stage kidney disease (ESKD), and the decrease in patients receiving home therapy, including peritoneal dialysis, the Korean Society of Nephrology has proclaimed the new policy, Kidney Health Plan 2033 (KHP 2033). KHP 2033 would serve as a milestone to bridge the current issues to a future solution by directing the prevention and progression of CKD and ESKD, particularly diabetic kidney disease, and increasing the proportion of home therapy, thereby reducing the socioeconomic burden of kidney disease and improving the quality of life. Here, we provide the background for the necessity of KHP 2033, as well as the contents of KHP 2033, and enlighten the Korean Society of Nephrology’s future goals. Together with patients, healthcare providers, academic societies, and national policymakers, we need to move forward with goal-oriented drive and leadership to achieve these goals.  
		                        		
		                        		
		                        		
		                        	
2.Crohn’s Disease Identified as Granulomatous Tubulointerstitial Nephritis
Jung Suk HAN ; Bum Soon CHOI ; Cheol Whee PARK ; Yeong Jin CHOI ; Chul Woo YANG ; Han Hee LEE ; Tae Hyun BAN
Korean Journal of Medicine 2022;97(3):186-190
		                        		
		                        			
		                        			 Crohn’s disease is usually diagnosed according to intestinal symptoms, but extra-intestinal manifestations are important in approximately one-third of cases. Although several extra-intestinal symptoms associated with various organs have been reported, renal involvement is uncommon in patients with Crohn’s disease. Tubulointerstitial nephritis in a patient with Crohn’s disease is usually caused by infection, sarcoidosis, or medications. However, primary tubulointerstitial nephritis caused by Crohn’s disease alone is extremely rare. A 19-year-old male patient was referred to our hospital because of an increase in serum creatinine level. He underwent a kidney biopsy with renal insufficiency. Renal histological findings revealed granulomatous tubulointerstitial nephritis. Thereafter, a colonoscopy was performed with suspicion of Crohn’s disease. Ultimately, he was diagnosed with granulomatous tubulointerstitial nephritis based on Crohn’s disease. The patient had improved gastrointestinal symptoms after the last treatment. This case report presents a rare case of primary tubulointerstitial nephritis caused by Crohn’s disease. 
		                        		
		                        		
		                        		
		                        	
3.Mortality prediction of serum neutrophil gelatinase-associated lipocalin in patients requiring continuous renal replacement therapy
Yohan PARK ; Tae Hyun BAN ; Hyung Duk KIM ; Eun Jeong KO ; Jongmin LEE ; Seok Chan KIM ; Cheol Whee PARK ; Chul Woo YANG ; Yong-Soo KIM ; Byung Ha CHUNG
The Korean Journal of Internal Medicine 2021;36(2):392-400
		                        		
		                        			 Background/Aims:
		                        			We investigated whether serum neutrophil gelatinase-associated lipocalin (NGAL) can predict mortality in patients with acute kidney injury (AKI) requiring continuous renal replacement therapy (CRRT). 
		                        		
		                        			Methods:
		                        			This study enrolled 169 patients who underwent serum NGAL testing at CRRT initiation from June 2017 to January 2019. The predictive power of serum NGAL level for 28-day mortality was compared to the Acute Physiology and Chronic Health Evaluation-II (APACHE-II) score and Sequential Organ Failure Assessment (SOFA) score via area under the receiver operating characteristic curve (AuROC) value. 
		                        		
		                        			Results:
		                        			There were 55 survivors and 114 non-survivors at 28 days post-CRRT initiation. Median serum NGAL level was significantly higher in the non-survivor group than in the survivor group (743.0 ng/mL vs. 504.0 ng/mL, p = 0.003). The AuROC value of serum NGAL level was 0.640, which was lower than APACHEII score and SOFA score values (0.767 and 0.715, respectively). However, in the low APACHE-II score group (< 27.5), AuROC value of serum NGAL was significantly increased (0.698), and it was an independent risk factor for 28 day-mortality (hazard ratio, 2.405; 95% confidence interval, 1.209 to 4.783; p = 0.012). 
		                        		
		                        			Conclusions
		                        			In patients with AKI requiring CRRT, serum NGAL levels may be useful for predicting short-term mortality in those with low APACHE-II scores. 
		                        		
		                        		
		                        		
		                        	
4.A New Self-management Scale with a Hierarchical Structure for Patients with Type 2 Diabetes
Eun-Hyun LEE ; Young Whee LEE ; Duck hee CHAE ; Kwan-Woo LEE ; Jin Ook CHUNG ; Seong bin HONG ; So Hun KIM ; Eun Hee KANG
Asian Nursing Research 2020;14(4):249-256
		                        		
		                        			Purpose:
		                        			The aims of this study were to develop a new instrument for measuring self-management with a hierarchical structure [the Diabetes Self-Management Scale (DSMS)] in patients with type 2 diabetes, and evaluate its psychometric properties. 
		                        		
		                        			Methods:
		                        			The DSMS instrument was developed in three phases: (1) conceptualization and item generation; (2) content validity and pilot testing; and (3) field testing of its psychometric properties. A convenience sample of 473 participants was recruited in three university hospitals and one regional health center, South Korea. 
		                        		
		                        			Results:
		                        			Exploratory and confirmatory factor analyses yielded two second-order component models explaining the common variance among six first-order factors. Principal axis factoring with a varimax rotation accounted for 60.88% of the variance. Confirmatory factor analysis of the hierarchical structure revealed the following fit indices: χ2/df = 1.373, standardized root-mean-square residual = .050, goodness-of-fit index = .935, incremental fit index = .975, comparative fit index = .974, and root-mean-square error of approximation = .039. All Cronbach' α values for internal consistency exceeded the criterion of .70. All of the intraclass correlation coefficients for test–retest reliability exceeded .70 except that for the taking-medication subscale. The components of the DSMS were moderately correlated with the comparator measures of self-efficacy and health literacy administered for convergent validity. 
		                        		
		                        			Conclusion
		                        			The DSMS is a new instrument for measuring the complex nature of self-management in patients with type 2 diabetes, comprising 17 items scored on a five-point Likert scale. The DSMS exhibits satisfactory psychometric properties for five reliability and validity metrics, and so is a suitable instrument to apply in both research and clinical practices.
		                        		
		                        		
		                        		
		                        	
5.A New Self-management Scale with a Hierarchical Structure for Patients with Type 2 Diabetes
Eun-Hyun LEE ; Young Whee LEE ; Duck hee CHAE ; Kwan-Woo LEE ; Jin Ook CHUNG ; Seong bin HONG ; So Hun KIM ; Eun Hee KANG
Asian Nursing Research 2020;14(4):249-256
		                        		
		                        			Purpose:
		                        			The aims of this study were to develop a new instrument for measuring self-management with a hierarchical structure [the Diabetes Self-Management Scale (DSMS)] in patients with type 2 diabetes, and evaluate its psychometric properties. 
		                        		
		                        			Methods:
		                        			The DSMS instrument was developed in three phases: (1) conceptualization and item generation; (2) content validity and pilot testing; and (3) field testing of its psychometric properties. A convenience sample of 473 participants was recruited in three university hospitals and one regional health center, South Korea. 
		                        		
		                        			Results:
		                        			Exploratory and confirmatory factor analyses yielded two second-order component models explaining the common variance among six first-order factors. Principal axis factoring with a varimax rotation accounted for 60.88% of the variance. Confirmatory factor analysis of the hierarchical structure revealed the following fit indices: χ2/df = 1.373, standardized root-mean-square residual = .050, goodness-of-fit index = .935, incremental fit index = .975, comparative fit index = .974, and root-mean-square error of approximation = .039. All Cronbach' α values for internal consistency exceeded the criterion of .70. All of the intraclass correlation coefficients for test–retest reliability exceeded .70 except that for the taking-medication subscale. The components of the DSMS were moderately correlated with the comparator measures of self-efficacy and health literacy administered for convergent validity. 
		                        		
		                        			Conclusion
		                        			The DSMS is a new instrument for measuring the complex nature of self-management in patients with type 2 diabetes, comprising 17 items scored on a five-point Likert scale. The DSMS exhibits satisfactory psychometric properties for five reliability and validity metrics, and so is a suitable instrument to apply in both research and clinical practices.
		                        		
		                        		
		                        		
		                        	
6.Clinical significance of red blood cell distribution width in the prediction of mortality in patients on peritoneal dialysis.
In O SUN ; Byung Ha CHUNG ; Hyun Ju YOON ; Jeong Ho KIM ; Bum Soon CHOI ; Cheol Whee PARK ; Yong Soo KIM ; Chul Woo YANG ; Kwang Young LEE
Kidney Research and Clinical Practice 2016;35(2):114-118
		                        		
		                        			
		                        			BACKGROUND: In this study, we assessed whether red blood cell distribution width (RDW) was associated with all-cause mortality in patients on peritoneal dialysis (PD) and evaluated its prognostic value. METHODS: This study included 136 patients who had RDW levels at PD initiation from January 2007 to January 2014 at the Presbyterian Medical Center and Seoul St. Mary's Hospital. We divided these patients into 2 groups (survivors vs. nonsurvivors), compared their clinical characteristics, and analyzed the predictors of survival. RESULTS: The study included 79 men and 57 women, with a mean age of 54 years (range, 15-85 years). The mean follow-up duration was 32 months (range, 1-80 months). Of 136 patients, 14 died during the follow-up period. When clinical characteristics of survivors (n = 122) and nonsurvivors (n = 14) were compared, no differences were identified, with the exception of serum albumin, total iron-binding capacity (TIBC), left ventricular ejection fraction, total leukocyte count, and RDW value. Survivors had higher serum albumin (3.4 ± 0.5 vs. 3.0 ± 0.5 g/dL, P < 0.001) and left ventricular ejection fraction (56.8 ± 9.8 vs. 48.7 ± 12.8, P = 0.040) and lower TIBC (213.4 ± 40.9 vs. 252.8 ± 65.6, P = 0.010), total leukocyte counts (6.9 × 103/μL vs. 8.6 × 103/μL, P = 0.009), and serum RDW values (13.9 ± 1.7 vs. 16.0 ± 1.8, P < 0.001). Patients with high RDW levels (≥ 14.8) showed significantly higher all-cause mortality than patients with low RDW levels (< 14.8, P < 0.001). In multivariate-adjusted Cox analysis, RDW and TIBC at the start of PD were independent risk predictors for all-cause mortality. CONCLUSION: RDW could be an additive predictor for all-cause mortality in patients on PD.
		                        		
		                        		
		                        		
		                        			Erythrocyte Indices
		                        			;
		                        		
		                        			Erythrocytes*
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Follow-Up Studies
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Leukocyte Count
		                        			;
		                        		
		                        			Male
		                        			;
		                        		
		                        			Mortality*
		                        			;
		                        		
		                        			Peritoneal Dialysis*
		                        			;
		                        		
		                        			Protestantism
		                        			;
		                        		
		                        			Seoul
		                        			;
		                        		
		                        			Serum Albumin
		                        			;
		                        		
		                        			Stroke Volume
		                        			;
		                        		
		                        			Survivors
		                        			
		                        		
		                        	
7.A Structural Equation Model Linking Health Literacy to Self-efficacy, Self-care Activities, and Health-related Quality of Life in Patients with Type 2 Diabetes.
Eun Hyun LEE ; Young Whee LEE ; Seung Hei MOON
Asian Nursing Research 2016;10(1):82-87
		                        		
		                        			
		                        			PURPOSE: Health literacy has been attracting increasing attention because low health literacy is considered an important predictor of adverse health outcomes in many chronic conditions, including diabetes. However, it is unclear how health literacy is associated with health outcomes. The purpose of this study was to formulate a hypothetical structural equation model linking health literacy to self-efficacy, self-care activities, and health-related quality of life (HRQOL) in patients with type 2 diabetes. METHODS: cross-sectional survey design was employed, and 459 patients with type 2 diabetes were recruited from outpatient clinics in two university hospitals. The patients completed a pack of questionnaires. The hypothetical model was tested using structural equation modeling analysis. RESULTS: The values of multiple fit indices indicated that the proposed model provided a good fit to the data. Health literacy exerted not only a direct effect on self-care activities, but also an indirect effect on self-care activities via self-efficacy. However, health literacy exerted only an indirect effect on HRQOL. This structural model was invariant across hemoglobin-A1c-controlled and hemoglobin-A1c-uncontrolled groups. Based on R2 values, the final model accounted for 20.0% of the variance in selfefficacy, 61.0% of the variance in self-care activities, and 16.0% of the variance in HRQOL. CONCLUSIONS: This study suggests that self-care activities are crucial to the link between health literacy and HRQOL. Both health literacy and self-efficacy need to be considered in clinical practice for enhancing self-care activities in patients with type 2 diabetes. This approach may ultimately improve HRQOL in these patients.
		                        		
		                        		
		                        		
		                        			Adult
		                        			;
		                        		
		                        			Aged
		                        			;
		                        		
		                        			Aged, 80 and over
		                        			;
		                        		
		                        			Cross-Sectional Studies
		                        			;
		                        		
		                        			Diabetes Mellitus, Type 2/*nursing/*psychology
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			*Health Knowledge, Attitudes, Practice
		                        			;
		                        		
		                        			*Health Literacy
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Male
		                        			;
		                        		
		                        			Middle Aged
		                        			;
		                        		
		                        			Models, Theoretical
		                        			;
		                        		
		                        			Quality of Life/*psychology
		                        			;
		                        		
		                        			Republic of Korea
		                        			;
		                        		
		                        			Self Care/*psychology
		                        			;
		                        		
		                        			*Self Efficacy
		                        			;
		                        		
		                        			Surveys and Questionnaires
		                        			;
		                        		
		                        			Young Adult
		                        			
		                        		
		                        	
8.Metformin induced acute pancreatitis and lactic acidosis in a patient on hemodialysis.
Yeon Kyung LEE ; Kihyun LIM ; Su Hyun HWANG ; Young Hwan AHN ; Gyu Tae SHIN ; Heungsoo KIM ; In Whee PARK
Yeungnam University Journal of Medicine 2016;33(1):33-36
		                        		
		                        			
		                        			Metformin, commonly prescribed for type 2 diabetes, is considered safe with minimal side-effect. Acute pancreatitis is rare but potentially fatal adverse side-effect of metformin. We report a patient on hemodialysis with metformin-related acute pancreatitis and lactic acidosis. A 62-year-old woman with diabetic nephropathy and hypertension presented with nausea and vomiting for a few weeks, followed by epigastric pain. At home, the therapy of 500 mg/day metformin and 50 mg/day sitagliptin was continued, despite symptoms. Laboratory investigations showed metabolic acidosis with high levels of lactate, amylase at 520 U/L (range, 30-110 U/L), and lipase at 1,250 U/L (range, 23-300 U/L). Acute pancreatitis was confirmed by computed tomography. No recognized cause of acute pancreatitis was identified. Metformin was discontinued. Treatment with insulin and intravenous fluids resulted in normalized amylase, lipase, and lactate. When she was re-exposed to sitagliptin, no symptoms were reported.
		                        		
		                        		
		                        		
		                        			Acidosis
		                        			;
		                        		
		                        			Acidosis, Lactic*
		                        			;
		                        		
		                        			Amylases
		                        			;
		                        		
		                        			Diabetes Mellitus
		                        			;
		                        		
		                        			Diabetic Nephropathies
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Hypertension
		                        			;
		                        		
		                        			Insulin
		                        			;
		                        		
		                        			Lactic Acid
		                        			;
		                        		
		                        			Lipase
		                        			;
		                        		
		                        			Metformin*
		                        			;
		                        		
		                        			Middle Aged
		                        			;
		                        		
		                        			Nausea
		                        			;
		                        		
		                        			Pancreatitis*
		                        			;
		                        		
		                        			Renal Dialysis*
		                        			;
		                        		
		                        			Sitagliptin Phosphate
		                        			;
		                        		
		                        			Vomiting
		                        			
		                        		
		                        	
9.The Effect of the Experience of Diabetes Education on Knowledge, Self-Care Behavior and Glycosylated Hemoglobin in Type 2 Diabetic Patients.
Seung Hei MOON ; Young Whee LEE ; Ok Kyung HAM ; Soo Hyun KIM
Journal of Korean Academic Society of Nursing Education 2014;20(1):81-92
		                        		
		                        			
		                        			PURPOSE: This study was to identify the effect of the experience of diabetes education on knowledge, self-care behavior and glycosylated hemoglobin (HbA1C). Further, this study was held to examine about patient's preferred methods of education and re-education frequency. METHODS: 166 type 2 diabetes patients from two hospitals in Incheon participated in this study. Data were analyzed by using descriptive analysis, t-test, ANOVA, Scheffe's test and multiple regression analysis. RESULTS: 72.3% patients needed re-education and the average interval of re-education was 8.53 months. Patients preferred education methods were lectures, practical training, and studying from pamphlet. Depending on the frequency of diabetes education, there were significant differences in the level of diabetes knowledge (F=10.88, p<.001) and self-care behaviors (F=4.59, p=.012), but there was not significant difference with HbA1C (F=1.53, p=.220). As to how much the diabetes education helped managing diabetes, there was a significant difference in the level of self-care behaviors (t=2.01, p=.049), but there were not significant differences in level of knowledge (t=1.10, p=.275) and HbA1C (t=-.33, p=.746). The experience of diabetes education was a significant factor which influenced patient's knowledge (t=3.93, p<.001) and self-care behaviors (t=2.21, p<.001). But HbA1C was not influenced by the experience of diabetes education (t=-1.68, p=.096). CONCLUSION: It is necessary to provide diabetes education with appropriate interval and methods and subjects that reflect the needs of patient through the study results.
		                        		
		                        		
		                        		
		                        			Education*
		                        			;
		                        		
		                        			Hemoglobin A, Glycosylated*
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Incheon
		                        			;
		                        		
		                        			Lectures
		                        			;
		                        		
		                        			Pamphlets
		                        			;
		                        		
		                        			Self Care*
		                        			
		                        		
		                        	
10.De novo glomerulitis associated with graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: A single-center experience.
Yul Hee CHO ; Seok Hui KANG ; Yaeni KIM ; Myung Hyun LEE ; Gun Hee AN ; Byung Ha CHUNG ; Bum Soon CHOI ; Chul Woo YANG ; Yong soo KIM ; Yeong Jin CHOI ; Cheol Whee PARK
Kidney Research and Clinical Practice 2013;32(3):121-126
		                        		
		                        			
		                        			BACKGROUND: Nephrotic syndrome (NS) and proteinuria are uncommon, often unrecognized manifestations of graft-versus-host disease (GVHD) after hematopoietic stem cell transplantation (HSCT). Only a few isolated case reports and case series involving smaller number of patients who developed NS after HSCT have been published. METHODS: We reviewed the renal histopathological examination findings and clinical records of 15 patients who developed proteinuria after HSCT at Seoul and Yeouido St. Mary's Hospital (Seoul, Korea). We also measured the anti-PLA2 Rantibodies (M-type phospholipase A2 receptor) in the serum samples from the seven patients at the time of renal biopsy. RESULTS: All patients had GVHD. The most common indication for biopsy was proteinuria ( > 1 g/day), with nine patients having nephrotic range proteinuria. The most common histopathological finding was membranous nephropathy (MN; n = 12).Other findings were membranoproliferative glomerulonephritis, C1q nephropathy, and diabetic nephropathy. Eleven patients were treated with immunosuppressive agents, and three patients were treated only with angiotensin II receptor blocker. The overall response rate, including complete remission (urinary protein level < 0.3 g/day) and partial remission (urinary protein level = 0.31-3.4 g/day), was 73%. The mean follow-up period was 26 months, and none of the patients developed end-stage renal disease. All of the seven patients with MN had negative findings for anti-PLA2R antibodies, measured using an enzyme-linked immunosorbent assay kit. CONCLUSION: In this study the findings of 15 renal biopsies were analyzed and to our knowledge this is the largest clinicopathological study of GVHD-related biopsy-proven nephropathy. Approximately 80% of the patients were MN and 73% responded either partially or completely to immunosuppressive treatment. Currently, there is an increase in the incidence of GVHD-mediated renal disease, and therefore, renal biopsy is essential for diagnosing the nephropathy and preventing the progression of renal disease.
		                        		
		                        		
		                        		
		                        			Antibodies
		                        			;
		                        		
		                        			Biopsy
		                        			;
		                        		
		                        			Diabetic Nephropathies
		                        			;
		                        		
		                        			Enzyme-Linked Immunosorbent Assay
		                        			;
		                        		
		                        			Follow-Up Studies
		                        			;
		                        		
		                        			Glomerulonephritis, Membranoproliferative
		                        			;
		                        		
		                        			Glomerulonephritis, Membranous
		                        			;
		                        		
		                        			Graft vs Host Disease*
		                        			;
		                        		
		                        			Hematopoietic Stem Cell Transplantation*
		                        			;
		                        		
		                        			Hematopoietic Stem Cells*
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Immunosuppressive Agents
		                        			;
		                        		
		                        			Incidence
		                        			;
		                        		
		                        			Kidney Failure, Chronic
		                        			;
		                        		
		                        			Nephrotic Syndrome
		                        			;
		                        		
		                        			Phospholipases A2
		                        			;
		                        		
		                        			Proteinuria
		                        			;
		                        		
		                        			Receptors, Angiotensin
		                        			
		                        		
		                        	
            
Result Analysis
Print
Save
E-mail